Vitreo Retinal Diseases – I

FP328 : Comparison of Intravitreal Ozurdex in Treatment Naã Ve Vs Refractory Diabetic Macular Edema (Dme)

Dr. Riddhi Arya, A13570, Dr. Manish Nagpal, Dr. Navneet Mehrotra

Diabetic Macular Edema (DME) is the leading cause for significant vision loss in the patients with diabetic retinopathy (DR)1. The inflammation has been noted as the leading events in disease development. It is observed that the increased permeability of macular capillaries in the course of hypoxia leads to increased levels of vascular endothelial growth factor (VEGF) and release of inflammatory factors, including chemokines, cytokines such as interleukin (IL)-6 and IL-8, and prostaglandins.

FP435 : A Study of Vitamin D Supplementation in Diabetic Retinopathy Patients with Type 2 Diabetes Mellitus

Dr. Smriti Jain, J18842, Dr. B Chandra Sekharan, Dr. Lubhani Jain

Diabetes Mellitus continues to be a major health burden all over the world. According to the latest data by the world health organisation, almost 422 million individuals are estimated to be suffering from diabetes mellitus.[1] The increasing trend towards unhealthy food practices, sedentary lifestyle and physical inactivity can be attributed to this rise in the burden of diabetes mellitus.

FP522 : Armour Study- Anti-Vegf in Neovascular Armd-Our Understanding in a Real World Indian Setting

Dr. Nimesh Jain, J15133, Dr. Naresh Kumar Yadav, Dr. Ashwin Mohan, Dr. Priya Srinivasan, Dr. Santosh Gopi Krishna Gadde

Age-related macular degeneration (AMD) is a multifactorial disease, predominantly affecting the central macula. It is a major ophthalmic concern across the globe and, with increased life expectancy coupled with growing risk factors particularly dietary habits, smoking, hypertension and obesity, incidence of AMD is expected to double by 2020.